Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroblastoma × Interviews as Topic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 38 Breast Neoplasms 27 Prostatic Neoplasms 24 Colorectal Neoplasms 20 Lung Neoplasms 14 Ovarian Neoplasms 9 Hematologic Neoplasms 9 Lymphoma 7 Hematopoietic and Lymphatic System Neoplasm 7 Leukemia 6 Uterine Cervical Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Endometrial Neoplasms 5 Depression 5 Urinary Bladder Neoplasms 4 Mouth Neoplasms 4 Motor Activity 4 Gastrointestinal Neoplasms 4 Anxiety Disorders 4 Advanced Cancer 4 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Disease 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Advanced Malignant Solid Neoplasm 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2

Interventions

Cyclophosphamide 45 Etoposide 25 Temozolomide 23 Melphalan 23 Irinotecan 23 3-Iodobenzylguanidine 21 Filgrastim 19 Topotecan 17 Carboplatin 17 Isotretinoin 16 fludarabine 15 Granulocyte Colony-Stimulating Factor 15 Peripheral Blood Stem Cell Transplantation 12 Granulocyte-Macrophage Colony-Stimulating Factor 12 Doxorubicin 12 Cisplatin 12 sargramostim 11 naxitamab 11 humanized 3F8 anti-GD2 monoclonal antibody 11 dinutuximab 11 Busulfan 11 fludarabine phosphate 10 Radiotherapy 10 Interleukin-2 10 Vincristine 9 Thiotepa 9 Vorinostat 7 Stem Cell Transplantation 7 Eflornithine 7 aldesleukin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡